Piskacek M[au] - Search Results

Year	Number of Results
1999	1
2000	1
2007	2
2008	1
2009	1
2012	1
2015	1
2016	2
2017	1
2018	2
2019	2
2020	1
2021	4
2022	3
2023	2
2024	0

1

Cryptic inhibitory regions nearby activation domains.

Knight A, Piskacek M. Knight A, et al. Among authors: piskacek m. Biochimie. 2022 Sep;200:19-26. doi: 10.1016/j.biochi.2022.05.004. Epub 2022 May 10. Biochimie. 2022. PMID: 35561946

2

The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD.

Houser J, Jendruchova K, Knight A, Piskacek M. Houser J, et al. Among authors: piskacek m. Biochem J. 2023 May 13;480(5):297-306. doi: 10.1042/BCJ20220605. Biochem J. 2023. PMID: 36825663

3

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients.

Hribkova H, Svoboda O, Bartecku E, Zelinkova J, Horinkova J, Lacinova L, Piskacek M, Lipovy B, Provaznik I, Glover JC, Kasparek T, Sun YM. Hribkova H, et al. Among authors: piskacek m. Front Cell Neurosci. 2022 Feb 23;16:830757. doi: 10.3389/fncel.2022.830757. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35281293 Free PMC article.

4

Universal two-point interaction of mediator KIX with 9aaTAD activation domains.

Hofrova A, Lousa P, Kubickova M, Hritz J, Otasevic T, Repko M, Knight A, Piskacek M. Hofrova A, et al. Among authors: piskacek m. J Cell Biochem. 2021 Oct;122(10):1544-1555. doi: 10.1002/jcb.30075. Epub 2021 Jul 5. J Cell Biochem. 2021. PMID: 34224597

5

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma.

Knight A, Rihova L, Kralova R, Penka M, Adam Z, Pour L, Piskacek M, Hajek R. Knight A, et al. Among authors: piskacek m. J Clin Med. 2021 Aug 20;10(16):3717. doi: 10.3390/jcm10163717. J Clin Med. 2021. PMID: 34442012 Free PMC article.

6

The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4.

Piskacek M, Otasevic T, Repko M, Knight A. Piskacek M, et al. Stem Cell Rev Rep. 2021 Oct;17(5):1934-1936. doi: 10.1007/s12015-021-10225-8. Epub 2021 Aug 3. Stem Cell Rev Rep. 2021. PMID: 34342803 No abstract available.

7

The 9aaTAD Transactivation Domains: From Gal4 to p53.

Piskacek M, Havelka M, Rezacova M, Knight A. Piskacek M, et al. PLoS One. 2016 Sep 12;11(9):e0162842. doi: 10.1371/journal.pone.0162842. eCollection 2016. PLoS One. 2016. PMID: 27618436 Free PMC article.

8

Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathways.

Piskacek M, Havelka M, Jendruchova K, Knight A. Piskacek M, et al. J Steroid Biochem Mol Biol. 2019 Mar;187:118-123. doi: 10.1016/j.jsbmb.2018.11.008. Epub 2018 Nov 20. J Steroid Biochem Mol Biol. 2019. PMID: 30468856

9

The 9aaTAD Is Exclusive Activation Domain in Gal4.

Piskacek M, Havelka M, Rezacova M, Knight A. Piskacek M, et al. PLoS One. 2017 Jan 5;12(1):e0169261. doi: 10.1371/journal.pone.0169261. eCollection 2017. PLoS One. 2017. PMID: 28056036 Free PMC article.

10

Do human B-lymphocytes avoid aging until 60 years?

Knight A, Nemec P, Bretzova S, Valkova L, Kolmanova M, Vytopilova R, Havelka M, Vsianska P, Rihova L, Krejci M, Piskacek M. Knight A, et al. Among authors: piskacek m. Oncotarget. 2016 Jul 12;7(28):42873-42880. doi: 10.18632/oncotarget.10146. Oncotarget. 2016. PMID: 27344181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year